Repetitive transcranial magnetic stimulation(rTMS)of the primary motor cortex has been reported to be effective for the treatment of various types of neuropathic pain.
Introduction
Post-stroke pain is a subset of neuropathic pain, and appears secondarily to the primary lesion of the central nervous system caused by the stroke. Dejerine and Roussy (1) first reported in 1906 that post-stroke pain is caused mainly by the thalamic lesion. However, other researchers contend that an extra-thalamic lesion can be the cause of post-stroke pain (2) . It has been suggested that approx. 8％ -14％ of post-stroke patients feel unpleasant or intractable pain (3, 4) , and the persistence of this pain markedly decreases the affected patientsʼ quality of life. A mechanism of post-stroke pain has been proposed; it involves a complex group of factors such as changes in the plasticity of synaptic degeneration or conduction efficiency (5) . Post-stroke pain has been described as one of the most difficult types of pain to treat, and the spontaneous remission of post-stroke pain is rare (6) . Moreover, pharmacological therapy and relative nerve blocking have not induced a sufficient reduction of post-stroke pain (7, 8) .
Neurostimulation techniques have been tested for severe medically refractory post-stroke pain. For example, chronic motor cortex stimulation(MCS)was first applied as a treatment for post-stroke pain(9)( Fig. 1 ) . Several reports have indicated definite pain reduction following MCS treatment for post-stroke pain (10) (11) (12) ; however, the longterm follow-up results of MCS for post-stroke pain revealed a decrease in subjective pain scores of only approx. 50％ (13) . In addition, MCS requires a craniotomy under general anesthesia to place the electrode on the epidural space of the motor cortex. Thus, the identification of selection criteria for candidates for MCS therapy is important and may help to increase the effectiveness of chronic MCS.
Transcranial magnetic stimulation(TMS)has been developed and repetitive transcranial magnetic stimulation (rTMS)has been clinically applied for the treatment of neuropathic pain (14) (15) (16) (17) . The effectiveness of rTMS for the treatment of post-stroke pain has not yet been established.
The present study examined rTMS-induced analgesia in post-stroke pain patients.
Materials and Methods

Patient Population
Twenty patients with post-stroke pain were tested (Table  1) the application of 10 stimuli.
For the rTMS, the subject sat relaxed on a stimulation chair while a total of 500 stimuli at 5 Hz were delivered to the motor cortex, which corresponded to the site of the most severe pain on the lesion side. The stimulation intensity was 100％ of the RMT of the unaffected motor hand area with 50 pulses per train at 25-sec intertrain intervals.
The protocols used in this study were in accord with Wassermannʼs safety guidelines for rTMS of the primary motor cortex (18) . According to those guidelines, the single trains of 5-Hz rTMS at 100％ RMT of stimulation intensity are applied for up to 10 sec in one session, and a total of 500 were considered to be a clinically significant improvement (20) .
Statistical Analyses
The intensities of pain as evaluated by the subjectsʼ VAS 
Results
The average reduction rate of the VAS score induced by improvement of pain was observed in the facial pain patient.
Discussion
Tsubokawa et al. (9) were the first researchers to demonstrate the efficacy of the electrical stimulation of the motor cortex in post-stroke pain, and several studies conducted since that 1991 report have shown the effectiveness of MCS therapy (21) (22) (23) (24) . rTMS has been shown to induce persistent changes in the central nervous system, noninvasively (25) . Based on the MCS studiesʼ findings, rTMS is currently being applied to neuropathic pain. High- (27) reported that the analgesic effect continued at least two weeks after rTMS was performed every day for five days. In the present study, one session of rTMS for primary motor cortex-induced analgesia lasted for 300 min in subjects with post-stroke pain, suggesting that further, rigorously designed studies will be of merit. We strongly stress that rTMS can be adapted for post-stroke pain patients, and it may be useful to select candidates for chronic MCS with epidural electrodes, since it has been reported that the success rate of chronic MCS is about 50％ (36) .
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